1.Skin Rash.
Journal of the Korean Medical Association 1999;42(7):700-703
No abstract available.
Exanthema*
;
Skin*
2.Skin Rashes in Children.
Journal of the Korean Pediatric Society 1998;41(4):431-431
No abstract available.
Child*
;
Exanthema*
;
Humans
;
Skin*
3.Pityriasis Rosea-Like Rash Secondary to Intravesical Bacillus Calmette-Guerin Immunotherapy.
Chee Won OH ; Jimi YOON ; Chi Yeon KIM
Annals of Dermatology 2012;24(3):360-362
No abstract available.
Bacillus
;
Exanthema
;
Immunotherapy
;
Pityriasis
4.Morbilliform rashes as sole manifestation of COVID-19
The Filipino Family Physician 2021;59(1):124-126
Coronavirus Disease 2019 (Covid-19), caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), is recognized as a worldwide public health crisis. It has rapidly spread from Wuhan City in China after an outbreak of flu-like illness. Respiratory symptoms remain the most common manifestation of Covid-19. However, dermatologic manifestations have been observed in patients with COVID-19 infection. Kulkharni, et al. published a case report of morbilliform rashes as a probable herald of Covid-19 being its initial and only manifestation of COVID-19.1 This is a case of a 45-year-old female who presented with worsening morbilliform rashes on both upper extremities and was initially diagnosed with allergic contact dermatitis. She had no respiratory symptoms and was eventually diagnosed with Covid-19 in a routine Reverse Transcription Polymerase Chain Reaction test (RT-PCR). She was subsequently admitted for treatment and recovered after 2 weeks of hospital stay.
Covid-19
;
Exanthema
5.Dermatological Side Effects of Anti-tumor Necrosis Factor Alpha Therapy.
Journal of Rheumatic Diseases 2014;21(1):9-19
As anti-tumor necrosis factor alpha (anti-TNFalpha) agents are progressively being used in various medical conditions, dermatological adverse events have been encountered more frequently. To understand such dermatological conditions that have been documented while undergoing anti-TNF therapy, we reviewed relevant literature, including case reports and case series. Reported dermatological conditions included infusion and injection site reaction, cutaneous infection, psoriasiform eruption, dermatitis, allergic rash, lupus-like lesion, vasculitis, lichenoid reaction, granulomatous reaction, hair loss, cutaneous infection, and cutaneous neoplasm. These events had varying strengths of causal association and severity therefore, drug discontinuation may or may not be required.
Dermatitis
;
Exanthema
;
Hair
;
Necrosis*
;
Vasculitis
6.Reevaluation of the importance of finding rash, lymphadenitis and eschars for the early clinical diagnosis of Tsutsugamushi disease.
Kang Su YI ; Sung Kun YOU ; Wan KO ; Won Young LEE ; Chin Ki PAI ; Ki Il KIM ; Yunsop CHONG
Korean Journal of Infectious Diseases 1991;23(3):163-169
No abstract available.
Diagnosis*
;
Exanthema*
;
Lymphadenitis*
;
Scrub Typhus*
7.Symmetrical Flexural and Intertriginous Exanthema: A Rare Manifestation Associated with COVID-19 Infection
Jin Yi Goh ; Huang Hin Chin ; Pek Woon Chin ; Masliza Zaid
Malaysian Journal of Dermatology 2021;46(June 2021):55-57
Summary
Cutaneous manifestations of Coronavirus disease (COVID-19) are variable. We present a case of non-drug related symmetrical flexural and intertriginous exanthema in a patient with COVID-19 infection. A 58-year-old Chinese male who was diagnosed to have COVID-19 infection, developed maculopapular erythematous rashes at bilateral axillary and inguinal folds on the fourth day of illness. He was treated symptomatically with anti-histamine and topical corticosteroid. The skin condition improved and he was discharged well on tenth day of illness. Although symmetrical flexural intertriginous exanthema isclassically caused by drug reaction, this case demonstrated the possibility of the rash being directly associated with COVID-19 infection. More cohorts should be evaluated to fully describe the full spectrum of dermatological manifestation in COVID-19.
Exanthema
;
COVID-19
;
Skin Manifestations
8.Predicting Factors of Roseola Infantum Infected with Human Herpesvirus 6 from Urinary Tract Infection.
Hong Ryul KO ; Son Moon SHIN ; Sung Won PARK
Childhood Kidney Diseases 2016;20(2):69-73
PURPOSE: The aim of this study was to compare the clinical and laboratory features of infants with roseola infantum due to human herpesvirus 6 (HHV6) infection and those with urinary tract infection (UTI). METHODS: We retrospectively reviewed the medical records of children who were hospitalized at Cheil General Hospital and Women's Health Care Center, College of Medicine, Dankook University, and diagnosed as having HHV6 infection or UTI. RESULTS: Among the infants admitted between September 2014 and May 2016, 92 (male, 45 and female, 47) were included in the study and divided into a HHV6 infection group (n=50) and a UTI group (n=42). The relative risk of UTI compared with that of HHV6 infection increased with pyuria (P<0.001), increased with leukocytosis (mean white blood cell [WBC] count, 15,048±5,756/mm³ vs 87,916±54,056/mm³; P<0.001), increased with C-reactive protein (CRP) level (4.89±4.85 mg/dL vs 1.04±1.76 mg/dL; P<0.001), and younger age (6.3±3.2 months vs 18.3±12.6 months; P<0.001). The relative risk of HHV6 infection compared with that of UTI increased with fever duration (4.3±1.7 days vs 2.8±1.7 days; P<0.001) and decreased with platelet (PLT) count (373±94×10³/mm³ vs 229±90×10³/mm³; P<0.001). No significant differences were found between the HHV6 groups according to the presence or absence of pyuria. CONCLUSION: Pyuria, age, fever duration, WBC count, CRP level, and PLT count were the differentiating factors of HHV6 infection from UTI. However, sterile pyuria can occur in children with HHV6 infection. In the presence of pyuria, CRP level and PLT count were the strong predictors of UTI compared with HHV6.
Blood Platelets
;
C-Reactive Protein
;
Child
;
Exanthema Subitum*
;
Female
;
Fever
;
Herpesvirus 6, Human*
;
Hospitals, General
;
Humans*
;
Infant
;
Leukocytes
;
Leukocytosis
;
Medical Records
;
Pyuria
;
Retrospective Studies
;
Urinary Tract Infections*
;
Urinary Tract*
;
Women's Health
9.Lamotrigine and Lithium in the Treatment of Acute Bipolar Disorder.
Young Joon KWON ; Hee Yeon JEONG ; In Joon PARK
Journal of Korean Neuropsychiatric Association 2001;40(5):885-892
BACKGROUND:To evaluate the efficacy of lamotrigine on bipolar disorder, both manic and depressed episode, the author compared the effects of lamotrigine with lithium and placebo. METHOD: Forty-seven manic patients with bipolar disorder and 43 depressed patients with bipolar disorder were treated with lamotrigine, lithium or placebo during 6 weeks. Their severity of symptoms were rated weekly using Young's Rating Scale for Mania and Hamilton Rating Scale for Depression. RESULTS: In manic patients the therapeutic efficacy of lamotrigine was lower than that of lithium during baseline to week 2, but after week 3, lamotrigine was as effective as lithium. In depressed patients the therapeutic efficacy of lamotrigine was superior to lithium from week 2 to endpoint. Most patients tolerated well except that one patient developed skin rashes. CONCLUSION: Lamotrigine seems to have antimanic and antidepressant effect as lithium in the treatment for acute bipolar disorder.
Bipolar Disorder*
;
Depression
;
Exanthema
;
Humans
;
Lithium*
10.Three Cases of Eruptive Pseudoangiomatosis in Adults.
Yoon Young KIM ; Mi Yeon KIM ; Young Min PARK ; Hyung Ok KIM
Korean Journal of Dermatology 2006;44(6):727-730
Eruptive pseudoangiomatosis (EPA) is a rare, benign, spontaneously-regressing exanthem. The term EPA was to describe a dermatosis characterized by the sudden onset of a few to several bright red angioma-like papules which is different histopathologically from true angioma. Herein we describe three cases of typical EPA in adults and review the literature. Based on our experience, it is likely that EPA has been misdiagnosed or underdiagnosed in the clinic and that it occurs more frequently in adults than previously reported.
Adult*
;
Exanthema
;
Hemangioma
;
Humans
;
Skin Diseases